盐酸阿比朵尔胶囊抗甲型H1N1流感病毒的体外实验研究

刘强 贺凤兰 刘媛媛 赵琳 代军朋 肖红 杨占秋

中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 108-112.

PDF(565 KB)
PDF(565 KB)
中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 108-112.
论著

盐酸阿比朵尔胶囊抗甲型H1N1流感病毒的体外实验研究

  • 刘强1,贺凤兰1,刘媛媛1,赵琳2,代军朋2,肖红1,杨占秋1*
作者信息 +

Inhibitory Effect of Arbidol Hydrochloride Capsule on Influenza Virus A H1N1 in Vitro

  • LIU Qiang1, HE Feng-lan1, LIU Yuan-yuan1 , ZHAO Lin2, DAI Jun-peng2,XIAO Hong1 , YANG Zhan-qiu1*
Author information +
文章历史 +

摘要

目的 评价盐酸阿比朵尔原料药、盐酸阿比朵尔胶囊(恩尔欣、奥司他韦胶囊(达菲对甲型流感病毒(H1N1的抑制效率,检验盐酸阿比朵尔胶囊替代奥司他韦胶囊用于流感治疗的可能性。方法 本实验以奥司他韦胶囊为阳性对照药物,采用细胞病变效应(CPE抑制法、噻唑蓝(MTT比色法和血凝滴度法对其抗甲型H1N1流感病毒的作用进行了观察。结果 盐酸阿比朵尔原料药、盐酸阿比朵尔胶囊、奥司他韦胶囊在安全浓度范围内,对100 TCID50(病毒半数组织感染量的甲型H1N1流感病毒均有一定抑制作用,且呈明显量-效关系。其中盐酸阿比朵尔原料药抗病毒生物合成作用、对病毒直接杀伤作用和抗病毒吸附、穿入作用三种方式的治疗指数(TI分别为(3.08±0.34、(3.55±0.54、(3.26±0.32;盐酸阿比朵尔胶囊的分别为(3.12±0.40、(3.41±0.23、(4.20±0.43;奥司他韦胶囊的依次为(5.34±0.26、(1.19±0.16、(1.01±0.38。结论 盐酸阿比朵尔原料药、盐酸阿比朵尔胶囊在阻断流感病毒吸附、穿入作用和直接杀伤作用方面较奥司他韦胶囊效果好(P<0.01。奥司他韦胶囊的抗病毒生物合成作用较盐酸阿比朵尔和盐酸阿比朵尔胶囊强(P<0.01,因此盐酸阿比朵尔胶囊可以替代奥司他韦胶囊用于预防甲型H1N1流感病毒感染。

Abstract

OBJECTIVE To investigate and compare the antiviral activity of arbidol hydrochloride, arbidol hydrochloride capsule and oseltamivir capsule (Tamiflu against influenza virus A (H1N1 in vitro. METHODS MTT colorimetric assay and hemagglutination titer assay was used to evaluate the antiviral activity of the drugs. Oseltamivir capsule was used as a positive control. RESULTS Arbidol, arbidol capsule and oseltamivir capsule prevented the cytopathic effect of influenza virus A (H1N1, and exhibited a significant dose-effect relationship. When drugs were added before, during or after viral infection, arbidol treatment index (TI were (3.08±0.34, (3.55±0.54, (3.26±0.32 respectively, while arbidol capsule TIS were (3.12 ± 0.40 and (3.41±0.23, (4.20±0.43 and the TIS of Oseltamivir capsule were (5.34±0.26, (1.19±0.16 and (1.01±0.38. CONCLUSION In vitro infection with influenza virus A (H1N1 can be effectively treated by arbidol, arbidol capsule and oseltamivir capsule. Arbidol and arbidol capsule were effective in directly killing virus and inhibiting viral absorption and penetration, while oseltamivir capsule is more significant in inhibiting viral biosynthesis. Arbidol capsule can substitute oseltamivir capsule for preventing against Influenza virus A (H1N1 infection.

关键词

盐酸阿比朵尔 / 奥司他韦 / 甲型H1N1流感病毒 / 抗病毒作用

Key words

arbidol hydrochloride / oseltamivir / influenza virus A (H1N1 / antiviral effect

引用本文

导出引用
刘强 贺凤兰 刘媛媛 赵琳 代军朋 肖红 杨占秋. 盐酸阿比朵尔胶囊抗甲型H1N1流感病毒的体外实验研究[J]. 中国药学杂志, 2011, 46(2): 108-112
LIU Qing;HE Feng-ln;LIU Yun-yun;ZHO Lin;DI Jun-peng;XIO Hong;YNG Zhn-qiu. Inhibitory Effect of Arbidol Hydrochloride Capsule on Influenza Virus A H1N1 in Vitro[J]. Chinese Pharmaceutical Journal, 2011, 46(2): 108-112

参考文献


[1] MCCLELLAN K, PERRY C M. Oseltamivir: a review of its use in influenza[J]. Drugs, 2001, 61(2: 263-283.
[2] LENEVA I A, ROBERTS N, GOVORKOVA E A, et al. The neuraminidase inhibitor GS4104 (oseltamivir phosphate is efficacious against A/Hong Kong/156/97 (H5N1 and A/Hong Kong/1074/99 (H9N2 influenza viruses[J]. Antiviral Res, 2000, 48(2: 101-115.
[3] Pandemic (H1N1 2009[OL]. World Health Organization. March, 2010. retrieved 2010-3-30 http://www. who. int/csr/disease/swineflu/laboratory1_04_2010/en/index. html.
[4] 2008-2009 Influenza Season Week 39 ending October 3, 2009[OL]. CDC of USA. October, 2009. retrieved 2010-3-30. http://www. cdc. gov/flu/weekly/weeklyarchives2008-2009/weekly39. htm.
[5] COLLINS P J, HAIRE L F, LIN Y P, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants[J]. Nature, 2008, 453(7199: 1258-1261.
[6] GLUSHKOV R G, GUS′KOVA T A, KRYLOVA L, et al. Mechanisms of arbidole′s immunomodulating action[J]. Vestn Ross Akad Med Nauk, 1999,(3:36-40.
[7] BORISKIN Y S, LENEVA I A, P CHEUR E I, et al. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion[J]. Curr Med Chem, 2008, 15(10: 997-1005.
[8] LENEVA I A, RUSSELL R J, BORISKIN Y S, et al. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol[J]. Antiviral Res, 2009, 81(2: 132-140.
[9] WHO. WHO manual on animal influenza diagnosis and surveillance (2002[S]. 2002. 21-24.
[10] HUANG Z X, HONG T, LIU C B, et al. Medical Virology Basis, Fundamental Techniques & Methods(医学病毒学基础及实验技术[M]. Beijing: Science Press ,1990:149-164.
[11] LU Q J, YUAN S P, REN J P, et al. Methodology of New Drug Research in Pharmacology(新药药理学研究方法[M]. Beijing: Chemical Industry Press, 2007: 278.
[12] YU R B, QIU H B, WANG N, et al. Medical Data Management and Analysis(医学研究的数据管理与分析[M]. Beijing: People′s Medical Publishing House, 2009:145.
[13] DAVID M K, PETER M H, DANE E G, et al. Fields Virology [M]. 5th ed. London: Lippincott Williams & Wilkins, 2007:1649.
[14] WOODS J M, BETHELL R C, COATES J A V, et al. 4-Guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase and of growth of a wide range of influenza A and B viruses in vitro[J]. Antimicrob Agents Chemother, 1993, 37(7:1473-1479.
PDF(565 KB)

Accesses

Citation

Detail

段落导航
相关文章

/